Chemomab Therapeutics (CMMB) Total Non-Current Liabilities (2011 - 2025)
Chemomab Therapeutics (CMMB) recorded Total Non-Current Liabilities of $179,000 in Q1 2025, down 36.1% from $280,000 a year earlier and down 14.4% from the prior quarter.
Powered by 
Analysis
Chemomab Therapeutics (CMMB) Total Non-Current Liabilities (2011 - 2025) Analysis & Trends
At the end of FY2024, Chemomab Therapeutics reported Total Non-Current Liabilities of $209,000, down 33.9% from FY2023.
- Annual Total Non-Current Liabilities has a five-year compound annual growth rate of -22.0% (FY2019 to FY2024).
- Across earlier years, Total Non-Current Liabilities came in at $316,000 in FY2023 (+247.3%), $91,000 in FY2022 (-61.6%), $237,000 in FY2021 (-33.8%) and $358,000 in FY2020 (-50.6%).
- The Q1 2025 figure is the lowest quarterly Total Non-Current Liabilities since Q3 2023.
- On a year-over-year basis, Total Non-Current Liabilities rose in three of the last seven quarters, with growth averaging 145.2%.
- Peak year-over-year performance for Total Non-Current Liabilities in the last five years was growth of 660.6% in Q2 2024, against a decline of 95.8% in Q3 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $209,000 (Q4 2024), $230,000 (Q3 2024) and $251,000 (Q2 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,130.22 Bn | 1,098.80 Bn | 19.71 Bn | 60.66 Bn |
| 2 | Johnson & Johnson | 614.95 Bn | 533.47 Bn | 17.26 Bn | 105.50 Bn |
| 3 | AbbVie | 505.05 Bn | 478.16 Bn | 12.70 Bn | 106.45 Bn |
| 4 | Merck | 368.08 Bn | 322.46 Bn | 12.21 Bn | 80.25 Bn |
| 5 | Novartis Ag | 298.32 Bn | 262.31 Bn | 11.24 Bn | 48.34 Bn |
| 6 | Astrazeneca | 261.58 Bn | 235.26 Bn | 12.86 Bn | 33.91 Bn |
| 7 | Amgen | 236.05 Bn | 191.45 Bn | 7.24 Bn | 78.66 Bn |
| 8 | Gilead Sciences | 190.61 Bn | 164.80 Bn | 6.22 Bn | 35.10 Bn |
| 9 | Pfizer | 169.86 Bn | 116.50 Bn | 10.94 Bn | 97.04 Bn |
| 10 | Chemomab Therapeutics | 7.53 Mn | -27.63 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2025 | 179,000.00 |
| Dec 31, 2024 | 209,000.00 |
| Sep 30, 2024 | 230,000.00 |
| Jun 30, 2024 | 251,000.00 |
| Mar 31, 2024 | 280,000.00 |
| Dec 31, 2023 | 316,000.00 |
| Sep 30, 2023 | 5,000.00 |
| Jun 30, 2023 | 33,000.00 |
| Mar 31, 2023 | 62,000.00 |
| Dec 31, 2022 | 91,000.00 |
| Sep 30, 2022 | 118,000.00 |
| Jun 30, 2022 | 148,000.00 |
| Mar 31, 2022 | 203,000.00 |
| Dec 31, 2021 | 237,000.00 |
| Sep 30, 2021 | 298,000.00 |
| Jun 30, 2021 | 320,000.00 |
| Mar 31, 2021 | 328,000.00 |
| Dec 31, 2020 | 358,000.00 |
| Dec 31, 2019 | 725,000.00 |
| Sep 30, 2019 | 6.26 Mn |
API Access
Chemomab Therapeutics Total Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=CMMB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-non-current-liabilities", "ticker": "CMMB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=CMMB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();